Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nucleotides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 2794 Cisplatin 2788 Carboplatin 2588 Radiotherapy 2485 Paclitaxel 2373 Gemcitabine 2226 pembrolizumab 2077 Docetaxel 1949 Bevacizumab 1922 Fluorouracil 1632 Capecitabine 1615 Oxaliplatin 1521 Dexamethasone 1393 Nivolumab 1369 Doxorubicin 1313 Rituximab 1308 Magnetic Resonance Spectroscopy 1208 Etoposide 1183 Irinotecan 1097 Leucovorin 1079 Drug Therapy 1047 Cytarabine 1001 fludarabine 928 Pemetrexed 924 Specimen Handling 868 Vincristine 830 Prednisone 828 Lenalidomide 827 Cetuximab 821 Trastuzumab 820

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01423799 2015-11-13

Neoimmune

Société des Produits Nestlé (SPN)

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡